The sle1 cell wall amidase is essential for β-lactam resistance in community-acquired methicillin-resistant staphylococcus aureus USA300

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

The sle1 cell wall amidase is essential for β-lactam resistance in community-acquired methicillin-resistant staphylococcus aureus USA300. / Thalsø-Madsen, Ida; Torrubia, Fernando Ruiz; Xu, Lijuan; Petersen, Andreas; Jensen, Camilla; Frees, Dorte.

I: Antimicrobial Agents and Chemotherapy, Bind 64, Nr. 1, e01931-19, 2020.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Thalsø-Madsen, I, Torrubia, FR, Xu, L, Petersen, A, Jensen, C & Frees, D 2020, 'The sle1 cell wall amidase is essential for β-lactam resistance in community-acquired methicillin-resistant staphylococcus aureus USA300', Antimicrobial Agents and Chemotherapy, bind 64, nr. 1, e01931-19. https://doi.org/10.1128/AAC.01931-19

APA

Thalsø-Madsen, I., Torrubia, F. R., Xu, L., Petersen, A., Jensen, C., & Frees, D. (2020). The sle1 cell wall amidase is essential for β-lactam resistance in community-acquired methicillin-resistant staphylococcus aureus USA300. Antimicrobial Agents and Chemotherapy, 64(1), [e01931-19]. https://doi.org/10.1128/AAC.01931-19

Vancouver

Thalsø-Madsen I, Torrubia FR, Xu L, Petersen A, Jensen C, Frees D. The sle1 cell wall amidase is essential for β-lactam resistance in community-acquired methicillin-resistant staphylococcus aureus USA300. Antimicrobial Agents and Chemotherapy. 2020;64(1). e01931-19. https://doi.org/10.1128/AAC.01931-19

Author

Thalsø-Madsen, Ida ; Torrubia, Fernando Ruiz ; Xu, Lijuan ; Petersen, Andreas ; Jensen, Camilla ; Frees, Dorte. / The sle1 cell wall amidase is essential for β-lactam resistance in community-acquired methicillin-resistant staphylococcus aureus USA300. I: Antimicrobial Agents and Chemotherapy. 2020 ; Bind 64, Nr. 1.

Bibtex

@article{0751177dd1924d429be26107f369f3f1,
title = "The sle1 cell wall amidase is essential for β-lactam resistance in community-acquired methicillin-resistant staphylococcus aureus USA300",
abstract = "Most clinically relevant methicillin-resistant Staphylococcus aureus (MRSA) strains have become resistant to β-lactams antibiotics through horizontal acquisition of the mecA gene encoding PBP2a, a peptidoglycan transpeptidase with low affinity for β-lactams. The level of resistance conferred by mecA is, however, strain dependent, and the mechanisms underlying this phenomenon remain poorly understood. We show here that β-lactam resistance correlates to expression of the Sle1 cell wall amidase in the fast-spreading and highly virulent community-acquired MRSA USA300 clone. Sle1 is a substrate of the ClpXP protease, and while the high Sle1 levels in cells lacking ClpXP activity confer β-lactam hyper-resistance, USA300 cells lacking Sle1 are as susceptible to β-lactams as cells lacking mecA. This finding prompted us to assess the cellular roles of Sle1 in more detail, and we demonstrate that high Sle1 levels accelerate the onset of daughter cells splitting and decrease cell size. Vice versa, oxacillin decreases the Sle1 level and imposes a cell separation defect that is antagonized by high Sle1 levels, suggesting that high Sle1 levels increase tolerance to oxacillin by promoting cell separation. In contrast, increased oxacillin sensitivity of sle1 cells appears linked to a synthetic lethal effect on septum synthesis. In conclusion, this study demonstrates that Sle1 is a key factor in resistance to β-lactam antibiotics in the JE2 USA300 model strain and that PBP2a is required for the expression of Sle1 in JE2 cells exposed to oxacillin.",
keywords = "Antibiotic resistance, Autolysins, Betalactams, Cell division, ClpXP protease, Daughter cell separation, MRSA, Sle1",
author = "Ida Thals{\o}-Madsen and Torrubia, {Fernando Ruiz} and Lijuan Xu and Andreas Petersen and Camilla Jensen and Dorte Frees",
year = "2020",
doi = "10.1128/AAC.01931-19",
language = "English",
volume = "64",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "1",

}

RIS

TY - JOUR

T1 - The sle1 cell wall amidase is essential for β-lactam resistance in community-acquired methicillin-resistant staphylococcus aureus USA300

AU - Thalsø-Madsen, Ida

AU - Torrubia, Fernando Ruiz

AU - Xu, Lijuan

AU - Petersen, Andreas

AU - Jensen, Camilla

AU - Frees, Dorte

PY - 2020

Y1 - 2020

N2 - Most clinically relevant methicillin-resistant Staphylococcus aureus (MRSA) strains have become resistant to β-lactams antibiotics through horizontal acquisition of the mecA gene encoding PBP2a, a peptidoglycan transpeptidase with low affinity for β-lactams. The level of resistance conferred by mecA is, however, strain dependent, and the mechanisms underlying this phenomenon remain poorly understood. We show here that β-lactam resistance correlates to expression of the Sle1 cell wall amidase in the fast-spreading and highly virulent community-acquired MRSA USA300 clone. Sle1 is a substrate of the ClpXP protease, and while the high Sle1 levels in cells lacking ClpXP activity confer β-lactam hyper-resistance, USA300 cells lacking Sle1 are as susceptible to β-lactams as cells lacking mecA. This finding prompted us to assess the cellular roles of Sle1 in more detail, and we demonstrate that high Sle1 levels accelerate the onset of daughter cells splitting and decrease cell size. Vice versa, oxacillin decreases the Sle1 level and imposes a cell separation defect that is antagonized by high Sle1 levels, suggesting that high Sle1 levels increase tolerance to oxacillin by promoting cell separation. In contrast, increased oxacillin sensitivity of sle1 cells appears linked to a synthetic lethal effect on septum synthesis. In conclusion, this study demonstrates that Sle1 is a key factor in resistance to β-lactam antibiotics in the JE2 USA300 model strain and that PBP2a is required for the expression of Sle1 in JE2 cells exposed to oxacillin.

AB - Most clinically relevant methicillin-resistant Staphylococcus aureus (MRSA) strains have become resistant to β-lactams antibiotics through horizontal acquisition of the mecA gene encoding PBP2a, a peptidoglycan transpeptidase with low affinity for β-lactams. The level of resistance conferred by mecA is, however, strain dependent, and the mechanisms underlying this phenomenon remain poorly understood. We show here that β-lactam resistance correlates to expression of the Sle1 cell wall amidase in the fast-spreading and highly virulent community-acquired MRSA USA300 clone. Sle1 is a substrate of the ClpXP protease, and while the high Sle1 levels in cells lacking ClpXP activity confer β-lactam hyper-resistance, USA300 cells lacking Sle1 are as susceptible to β-lactams as cells lacking mecA. This finding prompted us to assess the cellular roles of Sle1 in more detail, and we demonstrate that high Sle1 levels accelerate the onset of daughter cells splitting and decrease cell size. Vice versa, oxacillin decreases the Sle1 level and imposes a cell separation defect that is antagonized by high Sle1 levels, suggesting that high Sle1 levels increase tolerance to oxacillin by promoting cell separation. In contrast, increased oxacillin sensitivity of sle1 cells appears linked to a synthetic lethal effect on septum synthesis. In conclusion, this study demonstrates that Sle1 is a key factor in resistance to β-lactam antibiotics in the JE2 USA300 model strain and that PBP2a is required for the expression of Sle1 in JE2 cells exposed to oxacillin.

KW - Antibiotic resistance

KW - Autolysins

KW - Betalactams

KW - Cell division

KW - ClpXP protease

KW - Daughter cell separation

KW - MRSA

KW - Sle1

U2 - 10.1128/AAC.01931-19

DO - 10.1128/AAC.01931-19

M3 - Journal article

C2 - 31685469

AN - SCOPUS:85077016362

VL - 64

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 1

M1 - e01931-19

ER -

ID: 234208747